Schonfeld Strategic Advisors’s Ginkgo Bioworks DNA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-169,710	Closed	-$967K	–	2147
2025 Q1	$967K	Buy	169,710 +67,829	+67%	+$691K	0.01%	1316
2024 Q4	$1M	Buy	+101,881	New	+$873K	0.01%	1120
2024 Q3	–	Sell	-14,449	Closed	-$193K	–	2120
2024 Q2	$193K	Buy	14,449 +12,600	+681%	+$376K	﹤0.01%	1819
2024 Q1	$85.8K	Buy	+1,849	New	+$95.7K	﹤0.01%	1866
2023 Q2	–	Sell	-498	Closed	-$26.5K	–	2217
2023 Q1	$26.5K	Sell	498 -13,372	-96%	-$847K	﹤0.01%	1817
2022 Q4	$938K	Buy	13,870 +556	+4%	+$51.1K	0.01%	1184
2022 Q3	$1.66M	Buy	13,314 +5,009	+60%	+$597K	0.01%	968
2022 Q2	$790K	Buy	8,305 +6,800	+452%	+$829K	0.01%	1127
2022 Q1	$243K	Buy	+1,505	New	+$293K	﹤0.01%	1820

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Schonfeld Strategic Advisors's DNA Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Ginkgo Bioworks (DNA) in Q2 2025, closing a stake of 169,710 shares — an estimated $967K sold.

Schonfeld Strategic Advisors first reported a position in DNA in Q1 2022 and held it in 9 quarters. The position peaked at $1.66M in Q3 2022. 166 funds tracked by Wall St. Rank hold DNA as of Q2 2025.

Schonfeld Strategic Advisors reported no remaining Ginkgo Bioworks position as of Q2 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 169,710 Ginkgo Bioworks shares in Q2 2025, an estimated $967K.
Schonfeld Strategic Advisors first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 9 quarters.
Schonfeld Strategic Advisors's Ginkgo Bioworks position peaked at $1.66M in Q3 2022.
166 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.